Palvella Therapeutics (PVLA) FCF Margin Growth (3y) (2017 - 2024)
Palvella Therapeutics (PVLA) FCF Margin Growth (3y) (2017 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Palvella Therapeutics |
1.49 Bn |
1.23 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
-198,566.00 |
| Sep 30, 2023 |
16,583.00 |
| Jun 30, 2023 |
2,928.00 |
| Mar 31, 2023 |
-44,182.00 |
| Sep 30, 2022 |
-332,338.00 |
| Jun 30, 2022 |
-22,224.00 |
| Mar 31, 2022 |
-3,056.00 |
| Dec 31, 2021 |
136,430.00 |
| Sep 30, 2021 |
-33,525.00 |
| Jun 30, 2021 |
124,864.00 |
| Mar 31, 2021 |
-83,841.00 |
| Dec 31, 2020 |
-71,523.00 |
| Sep 30, 2020 |
-111,796.00 |
| Jun 30, 2020 |
29,137.00 |
| Mar 31, 2020 |
-203,422.00 |
| Dec 31, 2019 |
-24,023.00 |
| Sep 30, 2019 |
39,555.00 |
| Jun 30, 2019 |
35,599.00 |
| Mar 31, 2019 |
-33,533.00 |
| Dec 31, 2018 |
-227,563.00 |
